Nature CommunicationsGeneticsPeer-reviewed journal article
Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing
Pablo Baeza-CenturióniD, Belén MiñanaiD, André J. FaureiD, Mike Thompson, Sophie BonnaliD, Gioia QuarantaniiD, Joseph ClarkeiD, Ben LehneriD, Juan ValcárceliD
Abstract
Altered splicing is a frequent mechanism by which genetic variants cause disease and antisense oligonucleotides (AONs) that target pre-mRNA splicing have been approved as therapeutics for multiple pathologies including patient-customized treatments for rare diseases. However, the regulatory architecture of human exons remains poorly understood and AON discovery is currently slow and expensive, limiting the wider adoption of the approach. Here we show that that systematic deletion scans -which can be made experimentally at very low cost - provide an efficient strategy to chart the regulatory landscape of human exons and to rapidly identify effective splicing-modulating oligonucleotides in a fully quantitative manner. Our results suggest a mechanism for the evolutionary origins of unusually short microexons and the repression of transmembrane domain-encoding exons, and reveal a checkerboard architecture of sequential enhancers and silencers in a model alternative exon. Accurate prediction of the effects of deletions using deep learning provides a resource, DANGO, that maps the splicing regulatory landscape of all human exons and predicts effective splicing-altering antisense oligonucleotides genome-wide.
- organism: human
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: deep learning
- Citations
- 8
- FWCI
- 2.09
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- One-Size-Fits-Many: Antisense oligonucleotides for rescuing splicing mutations in hotspot exons
Chaorui Duan, Stephen Rong, … William Guy Fairbrother·bioRxiv·Dec 7, 2024
- OpenSplice: the impact of half a million mutations on the alternative splicing of 600 human exons
Gioia Quarantani, Joseph Clarke, … Ben Lehner·bioRxiv·May 23, 2026
- OpenASO: RNA Rescue--designing splice-modulating antisense oligonucleotides through community science
Victor Tse, Martin Guiterrez, … Michael D. Stone·RNAPeer-reviewed·May 27, 2025
- Mutations primarily alter the inclusion of alternatively spliced exons
Pablo Baeza-Centurión, Belén Miñana, … Ben Lehner·eLifePeer-reviewed·Oct 28, 2020
- Specificity and exon target space of splicing modifying compounds
Felina Lenkeit, Judith Knehr, … Alejandro Reyes·DOAJ (DOAJ: Directory of Open Access Journals)Peer-reviewed·Jul 1, 2026
- A deep learning approach to identify new gene targets of a novel therapeutic for human splicing disorders
Dadi Gao, Elisabetta Morini, … Susan A. Slaugenhaupt·bioRxiv·Feb 3, 2020